Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneview HealthcareASX:ONE 37 Debt-to-EBITDA is -0.19 as of Dec. 2025. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Oneview Healthcare ranks worse than 209643.4% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Oneview Healthcare's Debt-to-EBITDA or its related term are showing as below:
ASX:ONE'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.19 Med: -0.11 Max: -0.05
Current: -0.11
During the past 10 years, the highest Debt-to-EBITDA Ratio of Oneview Healthcare was -0.05. The lowest was -0.19. And the median was -0.11.
ASX:ONE's Debt-to-EBITDA is ranked worse than 100% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs ASX:ONE: -0.11
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Oneview Healthcare Debt-to-EBITDA Related Terms
Oneview Healthcare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Oneview Healthcare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ONE vs VEEV, BTSG, TEM: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Oneview Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Oneview Healthcare (ASX:ONE) has a Debt-to-EBITDA of -0.19 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Oneview Healthcare. According to the industry distribution chart, Oneview Healthcare ranks #999999 out of 477 companies in the Healthcare Providers & Services industry.
Is Oneview Healthcare's Debt-to-EBITDA too high?
Oneview Healthcare's current Debt-to-EBITDA is -0.19. Based on the distribution chart, Oneview Healthcare ranks #999999 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's Debt-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #999999 out of 477 companies for Debt-to-EBITDA. This places Oneview Healthcare in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Oneview Healthcare. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current Debt-to-EBITDA is -0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.17 — trading 48.5% below its estimated fair value. The current Debt-to-EBITDA is -0.19. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current Debt-to-EBITDA is -0.19 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 48.5% below its estimated GF Value™ of A$0.33.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
Debt-to-EBITDA: -0.19
GF Value™: A$0.33 vs. price of A$0.17 (48.5% below fair value)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
